Skip Navigation LinksHome   /   Reference Center   /   Publication List
  • Print
  • Share

 CIBMTR Publication List

Since 1972, use of CIBMTR data and statistical resources have resulted in more than 700 publications in peer-reviewed scientific journals. These publications are organized by year below, and can be searched to help you quickly find the information you need.
 

Display:



2014

Year Title Authors Publication
2014 Outcome of transplantation for acute lymphoblastic leukemia in children with down syndrome. Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kenneday-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang M-J, Eapen M, Carpenter PA Pediatr Blood Cancer 61(6):1126-1128
2014 Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang M-J, Eapen M Biol Blood Marrow Transplant 20(5):662-667
2014 Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1 and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia. Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Marsh SGE, Spellman S, Haagenson MD, Saeturn K, Ladner M, Trachtenberg E, Parham P, Miller JS J Immunol
2014 Lower risk of serious adverse events and no Increased risk of cancer after PBSC versus bone marrow donation. Blood
2014 Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation. Aplenc R, Zhang M-J, Sung L, Zhu X, Ho V, Cooke K, Dvorak C, Hale G, Lazarus H, McCarthy P, Olsson R, Pulsipher M, Pasquini M, Bunin N Blood
2014 Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission. Holter Chakrabarty JL, Rubinger M, Le-Rademacher J, Wang H-L, Grigg A, Selby GB, Szer J, Rowe JM, Weisdorf DJ, Tallman MS Biol Blood Marrow Transplant
2014 CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells from MDS patients against primary MDS and MDSC CD33+ targets. Gleason MK, Ross JA, Warlick ED, Lund TC, Verneris MR, Wiernik A, Spellman S, Haagenson MD, Levnik AJ, Litzow MR, Epling-Burnette PK, Blazar BR, Weiner LM, Weisdorf DJ, Vallera DA, Miller JS Blood
2014 Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. Wirk B, Fenske TS, Hamadani M, Zhang M-J, Hu Z-H, Akpek G, Aljurf MD, Armand P, Ayala E, Bachanova V, Bolwell B, Cairo MS, Cashen A, Chen Y-B, Costa LJ, Farhan S, Freytes CO, Gajewski JL, Gibson J, Hale GA, Holmberg LA, Hsu J, Inwards DJ, Kamble RT, Maharaj D, Maziarz RT, Munker R, Nath R, Reddy NM, Reeder CB, Rizzieri DA, Sauter CS, Savani BN, Schouten HC, Sureda A, Vose JM, Waller EK, Wiernik PH, Gale RP, Burns LJ, Saber W Biol Blood Marrow Transplant
2014 Allotransplantation for patients age 40 years and greater with non-Hodgkin Lymphoma (NHL): encouraging progression-free survival. McClune, Ahn KW, Wang H-L, Antin JH, Artz AS, Cahn J-Y, Deol A, Freytes C, Hamadani M, Holmberg LA, Jagasia MH, Jakubowski AA, Kharfan-Dabaja MA, Lazarus HM, Miller AM, Olsson R, Pedersen TL, Pidala J, Pulsipher MA, Rowe JM, Saber W, van Besien KW, Waller EK, Akpek G, Bacher U, Chao NJ, Chen Y-B, Cooper BW, Dehn J, de Lima MJ, de Lima MJ, Hsu JW, Lewis ID, Marks DI, McGuirk J, Cairo MS, Schouten HC, Szer J, Ramanathan M, Savani BN, Seftel M, Socie G, Vij R, Warlick ED, Weisdorf DJ Biol Blood Marrow Transplant
2014 Cytotoxic T-Lymphocyte antigen-4 (CTLA-4) single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplant: A Center for International Blood and Marrow Transplant Research Analysis. Sengsayadeth S, Wang T, Lee SJ, Haagenson MD, Spellman S, Fernandez Viña MA, Müller CR, Verneris MR, Savani BN, Jagasia M Biol Blood Marrow Transplant
2014 A randomized double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (Etanercept) for the treatment of idiopathic pneumonia syndrome following allogeneic stem cell transplantation: Blood and Marrow Transplant Clinical Trials Network. Biol Blood Marrow Transplant
2014 Survival improvements in adolescents and young adults following myeloablative allogeneic transplantation for acute lymphoblastic leukemia. Wood WA, Lee SJ, Brazzuskas R, Wang Z, Aljurf MD, Ballen KK, Buchbinder DK, Dehn J, Freytes CO, Lazarus HM, LeMaistre CF, Mehta P, Szwajcer D, Joffe S, Majhail NS Biol Blood Marrow Transplant
2014 Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens. Bitan M, He W, Zhang M-J, Hisham A-A, Ayas MF, Bielorai B, Carpenter PA, Cairo MS, Diaz MA, Horan JT, Jodele S, Kitko CL, Schultz KR, Kletzel M, Kasow KA, Lehmann LE, Mehta PA, Shah N, Pulsipher MA, Prestidge T, Seber A, Shenoy S, Woolfrey AE, Yu LC, Davies SM Blood 123(10):1615-1620
2014 Hematopoietic Cell Transplant Comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. Saad A, Mahindra A, Zhang M-J, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan AY, Kyle RA, Marks D, Nishihori T, Pasquini MC, Sagar L, Savani BN, Saber W, Sharma M, Sorror ML, Wirk BM, Hari PN Biol Blood Marrow Transplant 20(3):402-408
2014 Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer. Roth JA, Bensink ME, O'Donnell PV, Fuchs EJ, Eapen M, Ramsey SD J Comp Eff Res 3(2):135-144
2014 Does total body irradiation conditioning improve outcomes of myeloablative HLA-identical sibling transplants for chronic lymphocytic leukemia? Sabloff M, Sobecks RM, Ahn KW, Zhu X, de Lima M, Brown JR, Inamoto Y, Holland HK, Aljurf MD, Laughlin MJ, Kamble RT, Hsu JW, Wirk BM, Seftel M, Lewis ID, Arora M, Alyea EP, Kalaycio ME, Cortes J, Maziarz RT, Gale RP Biol Blood Marrow Transplant 20(3):421-424
2014 Second transplants for multiple myeloma relapsing after a prior autotransplant – reduced intensity allogeneic versus autologous transplantation. Freytes CO, Vesole DH, LeRademacher J, Zhong X, Gale RP, Kyle RA, Reece DE, Gibson J, Schouten HC, McCarthy PL, Lonial S, Krishnan AY, Dispenzieri A, Hari PN Bone Marrow Transplant 49(3):416-421
2014 Treatment of older patients with high-risk myelodysplastic syndromes (MDS): The emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT). Atallah E, Bylow K, Troy J, Saber W Curr Hematol Malig Rep 9(1):57-65
2014 Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allotransplantation: Impact of imatinib and minimal residual disease. Bachanova V, Marks DI, Zhang M-J, Wang H, de Lima M, Aljurf MD, Arellano M, Artz AS, Bacher U, Cahn J-Y, Chen Y-B, Copelan EA, Drobyski WR, Gale RP, Greer JP, Gupta V, Hale GA, Kebriaei P, Lazarus HM, Lewis ID, Liesveld JL, Litzow MR, Loren AW, Miller AM, Norkin M, Oran B, Pidala J, Rowe JM, Savani BN, Saber W, Vij R, Waller EK, Wiernik PH, Weisdorf DJ Leukemia 28(3):658-665
2014 Comparison of statistics in association tests of genetic markers for survival outcomes. Mendolia F, Klein JP, Petersdorf EW, Malkki M, Wang T Stat Med 33(5):828-844
2014 Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a CIBMTR-Eurocord Analysis. Weisdorf D, Eapen M, Ruggeri A, Zhang M-J, Zhong X, Brunstein C, Ustun C, Rocha V, Gluckman E Biol Blood Marrow Transplant
2014 Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. Fernandez-Viña MA, Wang T, Lee SJ, Haagenson M, Aljurf M, Askar M, Battiwalla M, Baxter-Lowe L-A, Gajewski J, Jakubowski AA, Marino S, Oudshoorn M, Marsh SGE, Petersdorf EW, Schultz K, Turner EV, Waller EK, Woolfrey A, Umejiego J, Spellman SR, Setterholm M Blood 123(8):1270-1278
2014 Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors. Marks DI, Ahn KW, Xiaobo Z, Appelbaum, Bachanova V, Barker JN, Brunstein CG, Gibson J, Kebriaei P, Lazarus HM, Olsson R, Perales, Pidala J, Savani B, Rocha V, Eapen M Haematologica 99(2):322-328
2014 Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007. Ferrara JL Biol Blood Marrow Transplant 20(2):149-153
2014 Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation. Kelly MJ, Horan JT, Alonzo TA, Eapen M, Gerbing RB, He W, Lange BJ, Parsons SK, Woods WG Pediatr Blood Cancer 61(2):269-275
2014 Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. Warlick ED, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn J-Y, Bornhauser M, Seftel, Matthew, Cairo MS, Laughlin, MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen Y-B, Liesveld JL, Cutler, CS, Ghobadi A, Uy, JL, Eapen M, Weisdorf DJ, Litzow, MR Biol Blood Marrow Transplant 20(2):202-208
2014 Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007. Biol Blood Marrow Transplant 20(2):149-153
2014 Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. Fenske TS, Zhang MJ, Carreras J, Ayala E, Burns LJ, Cashen A, Costa LJ, Freytes CO, Gale RP, Hamadani M, Holmberg LA, Inwards DJ, Lazarus HM, Maziarz RT, Munker R, Perales MA, Rizzieri DA, Schouten HC, Smith SM, Waller EK, Wirk BM, Laport GG, Maloney DG, Montoto S, Hari P J Clin Oncol 32(4):273-281
2014 Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. Eckrich MJ, Ahn KW, Champlin RE, Coccia P, Godder K, Horan J, Margolis D, Deeg HJ, Eapen M Am J Hematol 89(2):125-129
2014 Clinical guide to fertility preservation in hematopoietic cell transplant recipients. Joshi S, Savani B, Chow E, Gilleece M, Halter J, Jacobsohn D, Pidala J, Quinn G, Cahn J-Y, Jakubowski A, Kamani N, Lazarus H, Rizzo D, Schouten HC, Socie G, Stratton P, Sorror M, Warwick A, Wingard J, Loren A, Majhail N Bone Marrow Transplant
2014 Evaluation of peripheral blood stem cell quality in products transported by traditional courier or commercial overnight shipping services. Howard A, Chitphakdithai P, Waller EK, Harris W, Rosenthal H, Nelson W, Majhail N, Navarro W, Walvogel S, Lisy J, Uecker J, Miller J, Spellman SR Transfusion
2014 Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Eapen M, Klein JP, Ruggeri A, Spellman S, Lee SJ, Anasetti C, Arcese W, Barker JN, Baxter-Lowe LA, Brown M, Fernandez-Vina MA, Freeman J, He W, Iori AP, Horowitz MM, Locatelli F, Marino S, Maiers M, Michel G, Sanz GF, Gluckman E, Rocha V Blood 123(1):133-140
2014 Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the Center for International Blood and Marrow Transplant Research. Gupta V, Malone AK, Hari PN, Ahn KW, Hu Z-H, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, Savani BN, Schouten HC, Szer J, Cahn J-Y, de Lima MJ, Wirk B, Aljurf MD, Popat U, Bejanyan N, Litzow MR, Norkin M, Lewis ID, Hale GA, Woolfrey AE, Miller AM, Ustun C, Jagasia MH, Lill M, Maziarz RT, Cortes J, Kalaycio ME, Saber W Biol Blood Marrow Transplant 20(1):89-97
2014 Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN Protocol 0201. Switzer GE, Bruce JG, Harrington D, Haagenson M, Drexler R, Foley A, Confer D, Bishop M, Anderlini P, Rowley S, Leitman SF, Anasetti C, Wingard JR Biol Blood Marrow Transplant 20(1):118-127
 
 
​​​​​

Search Publications​
View current and planned studies
Last Updated: 3/16/2012 9:45 AM